Cargando…
Tolterodine extended release is well tolerated in older subjects
OBJECTIVES: To investigate the tolerability of tolterodine extended release (ER) in older subjects with overactive bladder (OAB). METHODS: This was a retrospective analysis of pooled data from five large, randomised, double-blind, placebo-controlled trials. Subjects with OAB symptoms, including urin...
Autores principales: | Griebling, T L, Kraus, S R, Richter, H E, Glasser, D B, Carlsson, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737749/ https://www.ncbi.nlm.nih.gov/pubmed/19624787 http://dx.doi.org/10.1111/j.1742-1241.2009.02108.x |
Ejemplares similares
-
Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER
por: Kaplan, S A, et al.
Publicado: (2014) -
Update on tolterodine extended-release for treatment of overactive bladder
por: Omotosho, Tola, et al.
Publicado: (2010) -
The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
por: Ulahannan, Danny, et al.
Publicado: (2009) -
Tolterodine extended release in the treatment of male oab/storage luts: a systematic review
por: Gacci, Mauro, et al.
Publicado: (2014) -
The effect of extended release tolterodine used for overactive bladder treatment on female sexual function
por: Zachariou, Athanasios, et al.
Publicado: (2017)